- Home
- INHD vs APM Comparison
INHD vs APM Comparison
Compare INHD & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- APM
- Stock Information
- Founded
- INHD 2019
- APM 2010
- Country
- INHD United States
- APM United Kingdom
- Employees
- INHD N/A
- APM N/A
- Industry
- INHD
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- APM Health Care
- Exchange
- INHD Nasdaq
- APM Nasdaq
- Market Cap
- INHD 19.8M
- APM 18.9M
- IPO Year
- INHD 2023
- APM 2018
- Fundamental
- Price
- INHD $3.84
- APM $1.80
- Analyst Decision
- INHD
- APM
- Analyst Count
- INHD 0
- APM 0
- Target Price
- INHD N/A
- APM N/A
- AVG Volume (30 Days)
- INHD 17.1M
- APM 20.5M
- Earning Date
- INHD 07-28-2025
- APM 04-30-2025
- Dividend Yield
- INHD N/A
- APM N/A
- EPS Growth
- INHD N/A
- APM N/A
- EPS
- INHD N/A
- APM N/A
- Revenue
- INHD $2,645,845.00
- APM N/A
- Revenue This Year
- INHD N/A
- APM N/A
- Revenue Next Year
- INHD N/A
- APM N/A
- P/E Ratio
- INHD N/A
- APM N/A
- Revenue Growth
- INHD 787.64
- APM N/A
- 52 Week Low
- INHD $1.11
- APM $0.46
- 52 Week High
- INHD $19.78
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- INHD 47.87
- APM 49.26
- Support Level
- INHD $3.60
- APM $1.64
- Resistance Level
- INHD $15.94
- APM $2.02
- Average True Range (ATR)
- INHD 2.25
- APM 0.16
- MACD
- INHD -0.39
- APM -0.04
- Stochastic Oscillator
- INHD 1.94
- APM 21.05
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.